Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,522 | -56,466 | -43,386 | -16,516 | -54,664 |
| Depreciation Amortization | 1,960 | 1,942 | 1,897 | 1,791 | 1,993 |
| Accounts receivable | -1,725 | N/A | N/A | N/A | N/A |
| Other Working Capital | -5,120 | -2,285 | -1,650 | 3,320 | 87 |
| Other Operating Activity | 5,670 | 2,606 | 10,039 | -18,367 | 32,316 |
| Operating Cash Flow | $-23,737 | $-54,203 | $-33,100 | $-29,772 | $-20,268 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,260 | 33,353 | 27,593 | -45,204 | -19,002 |
| PPE Investments | -26 | -21 | -181 | -643 | -135 |
| Investing Cash Flow | $3,234 | $33,332 | $27,412 | $-45,847 | $-19,137 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,446 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 82,800 | N/A |
| Debt Repayment | -207 | -193 | -157 | -20,631 | -32 |
| Common Stock Issued | N/A | 23,568 | 4 | 141 | 60,305 |
| Other Financing Activity | -300 | 4,644 | -50 | -1,147 | 1,195 |
| Financing Cash Flow | $4,939 | $28,019 | $-203 | $61,163 | $61,468 |
| Beginning Cash Position | 19,119 | 11,971 | 17,862 | 32,318 | 10,255 |
| End Cash Position | 3,555 | 19,119 | 11,971 | 17,862 | 32,318 |
| Net Cash Flow | $-15,564 | $7,148 | $-5,891 | $-14,456 | $22,063 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,737 | -54,203 | -33,100 | -29,772 | -20,268 |
| Capital Expenditure | -26 | -21 | -181 | N/A | N/A |
| Free Cash Flow | -23,763 | -54,224 | -33,281 | -29,772 | -20,268 |